Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of Viokase® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic Insufficiency

NCT00559364 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00559364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled, Phase III Study to Assess the Safety and Efficacy of Viokase® 16 for the Correction of Steatorrhea in Patients With Exocrine Pancreatic Insufficiency
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2007
Completion date
July 31, 2009
Enrollment
50 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, exocrine pancreatic insufficiency, pancreatectomy